Crossject Share Price
Stocks
ALCJ
FR0011716265
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
10:25:00 27/10/2026 pm IST
|
After hours 01:44:25 am | |||
| 1.254 EUR | -1.88% |
|
1.254 | 0.00% |
| 12/10 | Crossject: No market launch of Zepizure before H127 at best | AL |
| 25/09 | Crossject: H126. Quid novi sub sole? Not much. | AL |
| Market Cap | 6.83Cr 7.61Cr 6.3Cr 5.72Cr 11Cr 722.55Cr 11Cr 76Cr 30Cr 378.73Cr 29Cr 28Cr 1.2TCr | P/E 2026 * |
3.06x | P/E 2027 * | 2.41x |
|---|---|---|---|---|---|
| Enterprise Value | 5.04Cr 5.61Cr 4.65Cr 4.22Cr 7.88Cr 533.11Cr 7.98Cr 56Cr 22Cr 279.43Cr 21Cr 21Cr 886.12Cr | EV / Sales 2026 * |
0.83x | EV / Sales 2027 * | 0.33x |
| Free-Float |
92.46% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALCJ | Real-time | |
Börse Stuttgart
| 74C | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 74C | Delayed | |
|
Boerse Muenchen
| 74C | Real-time | |
|
Tradegate
| 74C | Real-time | |
|
CBOE
| Real-time |
| 1 day | -1.88% | ||
| Current month | -9.13% | ||
| 1 month | -6.14% | ||
| 3 months | -16.62% | ||
| 6 months | -35.69% | ||
| Current year | -42.74% |
| 1 week | 1.25 |  | 1.32 |
| 1 month | 1.1 | | 1.41 |
| Current year | 1.1 | | 2.58 |
| 1 year | 1.1 | | 2.7 |
| 3 years | 0.72 | | 5.96 |
| 5 years | 0.72 | | 5.96 |
| 10 years | 0.72 | | 7.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 08/08/2001 | |
Lionel Seltz
DFI | Director of Finance/CFO | - | 25/03/2026 |
Tony C. Tipton
PRN | Corporate Officer/Principal | - | 20/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Philippe Monnot
CHM | Chairman | 67 | 26/06/2009 |
Eric Nemeth
BRD | Director/Board Member | 67 | - |
| Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/07/25 | Buy | Director | 13,386 | 0.0266% | ||
| 01/07/25 | Buy | Director | 50 | 0.0001% | ||
| 01/07/25 | Buy | Director | 337 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.88% | 0.00% | -48.29% | -67.60% | 7.78Cr | |
| -1.70% | -0.92% | -18.72% | +9.70% | 18TCr | |
| -1.54% | +1.17% | -21.05% | +16.57% | 12TCr | |
| -0.89% | +1.27% | +0.30% | +33.51% | 12TCr | |
| +3.89% | +19.57% | -41.99% | +9.72% | 8.99TCr | |
| -1.40% | -4.30% | -2.21% | +72.52% | 6.3TCr | |
| +1.00% | +3.09% | +14.65% | +83.00% | 5.54TCr | |
| -0.69% | +2.25% | +4.95% | -23.27% | 5.35TCr | |
| -1.57% | +0.98% | -12.42% | +41.22% | 4.49TCr | |
| -0.66% | +5.54% | -5.79% | -8.14% | 3.39TCr | |
| Average | -0.41% | +3.36% | -13.06% | +16.72% | 7.56TCr | |
| Weighted average by Cap. | -0.29% | +3.30% | -12.48% | +23.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.08Cr 6.77Cr 5.61Cr 5.09Cr 9.51Cr 643.47Cr 9.63Cr 67Cr 27Cr 337.28Cr 25Cr 25Cr 1.07TCr | 6.52Cr 7.26Cr 6.02Cr 5.46Cr 10Cr 690.03Cr 10Cr 72Cr 29Cr 361.69Cr 27Cr 27Cr 1.15TCr |
| Net income | 66L 73.54L 60.94L 55.26L 1.03Cr 70Cr 1.05Cr 7.31Cr 2.9Cr 37Cr 2.76Cr 2.7Cr 116.1Cr | 86L 95.82L 79.41L 72.01L 1.35Cr 91Cr 1.36Cr 9.52Cr 3.78Cr 48Cr 3.6Cr 3.52Cr 151.29Cr |
| Net Debt | -1.79Cr -1.99Cr -1.65Cr -1.5Cr -2.8Cr -189.44Cr -2.84Cr -20Cr -7.87Cr -99Cr -7.49Cr -7.33Cr -314.89Cr | -4.7Cr -5.24Cr -4.34Cr -3.94Cr -7.36Cr -497.42Cr -7.45Cr -52Cr -21Cr -260.73Cr -20Cr -19Cr -826.8Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | €1.254 | -1.88% | 60,759 |
| 26/26/26 | €1.278 | -3.47% | 94,075 |
| 23/26/23 | €1.324 | +0.91% | 1,06,460 |
| 22/26/22 | €1.312 | +0.31% | 1,11,268 |
| 21/26/21 | €1.308 | +0.77% | 82,662 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALCJ Stock
Select your edition
All financial news and data tailored to specific country editions
